Those prescribed lansoprazole could encounter a range of side effects, some of which may signal a serious condition.

Teva Pharmaceuticals has voluntarily withdrawn its lansoprazole delayed-release orally disintegrating tablets (ODT) product from distribution after the FDA received reports of clogged and blocked oral ...

Lansoprazole oral capsule is a generic drug that’s used to treat conditions associated with increased stomach acid. Lansoprazole oral capsule is “delayed release,” which means the drug is released ...

Princeton, New Jersey; October 18, 2010 - Sandoz today announced the introduction of lansoprazole delayed-release orally disintegrating tablets (ODT), an authorized generic equivalent of Prevacid® ...

Dr. Reddy’s Laboratories has introduced an orally disintegrating formulation of lansoprazole to the U.S. market. The new product is the therapeutic equivalent of the Prevacid SoluTab delayed-release ...

Stomach pain can also be a common side effect that affects more than one in 100 people taking lansoprazole. While this pain ...

The pharmacokinetics and pharmacodynamics of lansoprazole suspension and lansoprazole capsules were studied. Thirty-six healthy males and females were randomized in a single-dose, open-label, ...

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) said Monday that it has launched Lansoprazole DR Orally Disintegrating Tablets, a therapeutic equivalent generic version of Prevacid SoluTab ...

Dr Reddy’s Laboratories Ltd announced the launch of US Food and Drug Administration (FDA) approved lansoprazole DR orally disintegrating tablets, a therapeutic equivalent generic version of Prevacid ...

To earn CME related to this news article, click here. January 21, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise of the potential for ...

JERUSALEM The Food and Drug Administration granted approval for Teva's abbreviated new drug application to market a generic version of a drug designed to treat peptic ulcers. The generic drug maker ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its ...